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Distinctive phenotypes and functions of innate
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During early pregnancy, decidual innate lymphoid cells (dILCs) interact with surrounding
maternal cells and invading fetal extravillous trophoblasts (EVT). Here, using mass cyto-
metry, we characterise ﬁve main dILC subsets: decidual NK cells (dNK)1–3, ILC3s and pro-
liferating NK cells. Following stimulation, dNK2 and dNK3 produce more chemokines than
dNK1 including XCL1 which can act on both maternal dendritic cells and fetal EVT. In contrast,
dNK1 express receptors including Killer-cell Immunoglobulin-like Receptors (KIR), indicating
they respond to HLA class I ligands on EVT. Decidual NK have distinctive organisation and
content of granules compared with peripheral blood NK cells. Acquisition of KIR correlates
with higher granzyme B levels and increased chemokine production in response to KIR
activation, suggesting a link between increased granule content and dNK1 responsiveness.
Our analysis shows that dILCs are unique and provide specialised functions dedicated to
achieving placental development and successful reproduction.
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In humans, the blastocyst implants into the mucosal lining ofthe uterus, the endometrium, that is transformed into deciduaunder the inﬂuence of progesterone. Interactions between
fetally-derived placental trophoblast cells and decidua are critical
to placental development and poor placentation is associated with
pregnancy complications such as pre-eclampsia and fetal growth
restriction1. Decidualisation involves all the elements of the
mucosa—glands, arteries, immune and stromal cells2. The most
abundant leucocytes populating ﬁrst trimester decidua are ILCs
with decidual NK cells (dNK) accounting for up to 70% of
decidual leucocytes3. In addition to dNK, the other major ILC
subsets, ILC1s—including intra-epithelial ILC1s, (ieILC1), ILC2s,
ILC3s, and LTi-like cells, have all been described within the
decidua but there is still no consensus about their exact pheno-
typic proﬁles and functional roles4–8.
dNK have been typically deﬁned as lineage negative (Lin-)
CD56superbright cells, distinct from peripheral blood NK cells
(pbNK) and other tissue-resident NK cells (trNK)9,10. Cytolytic
activity towards standard NK targets, such as K562 is weak and
IFNγ secretion only found after stimulation with IL-15 or IL-
211,12. Crucially, dNK have never been shown to kill normal
trophoblast and available evidence points to them playing a
physiological role, acting on extravillous trophoblast (EVT) and
maternal decidual cells through the production of factors such
as GM-CSF and XCL113–17. More recently, the considerable
heterogeneity in decidual ILCs is revealed from single cell RNA
sequencing (scRNAseq) analysis of isolates of ﬁrst trimester
decidual cells8. The RNA proﬁling suggests there are three main
dNK subsets (dNK1-3) together with proliferating NK cells
(dNKp) and an ILC3 population (dILC3). Compared with
dNK2 and dNK3 cells, dNK1 cells have large granules with
increased expression of perforin, granzymes as well as Killer-
cell immunoglobulin-like receptors (KIR), CD94/NKG2A and
LILRB1. Immunogenetic and functional studies suggest binding
of these NK receptors (NKR) to HLA class I ligands, HLA-C,
HLA-E, and HLA-G on EVT, triggers responses in dNK that
regulate maternal spiral artery remodelling to ensure adequate
blood supply to the growing fetus18–23.
Other evidence suggests that NK cell granules might play a role
in cytokine production. In pbNK from healthy individuals, cells
with larger granules are not only better killers, but also produce
more cytokines24. pbNK from patients with Chediak-Higashi
syndrome (CHS) possess NK cells with fewer, larger granules that
do not polarise towards canonical NK cell target cells compared
to normal pbNK25,26. Despite this, their cytokine production is
more efﬁcient27. These results have resonance with the para-
doxical ﬁndings for dNK that are poorly cytotoxic yet possess
large granules ﬁlled with perforin and granzymes.
ILCs exhibit considerable heterogeneity and ﬂexibility to
differentiate from one type to another, necessitating detailed
characterisation within each tissue type28. To describe in detail
the phenotype and function of dILCs, we have developed a
mass cytometry panel and stained matched blood and decidual
leucocytes from ﬁrst trimester pregnancies. Here, we deﬁne
protein markers that distinguish dILC subsets with distinct
roles in the decidua. There are three major subsets of dNK as
well as other uterine ILCs. We show that dILC populations are
highly diverse and display decidual-speciﬁc phenotype and
functions. dNK granule content and organisation is distinct
from that of pbNK. We also demonstrate that KIR acquisition
by dNK is associated with increased granule content at steady
state and increased functionality upon cross-linking of an
activating KIR. This comprehensive analysis of the phenotype
and functional characteristics of dILCs reveals their unique
features in this decidual environment dedicated to successful
reproduction.
Results
Decidual ILC subsets identiﬁed by mass cytometry. Initially, we
set out to characterise the heterogeneity of matched cryopre-
served ﬁrst trimester decidual mononuclear cells (dMCs) and
PBMCs using a 41-marker mass cytometry panel (Fig. 1a and
Supplementary Table 1). As this is the ﬁrst study of dMCs using
mass cytometry, we compared a subset of our panel of antibodies
with results generated by conventional ﬂow cytometry. All anti-
bodies behaved comparably across both platforms (Supplemen-
tary Fig. 1A, B, Supplementary Table 2). Few previous studies
have used cryopreserved dMCs and thus we also compared the
staining proﬁles for fresh and cryopreserved dMC samples by
mass cytometry (Supplementary Fig. 2A, B, Supplementary
Table 3). Although similar staining proﬁles were obtained, certain
markers were more sensitive to freezing and thawing such as
CD49a and there was also variation between donors (Supple-
mentary Fig. 2B, C).
To analyse all the ILC populations in blood and decidua, Lin-
mononuclear cells were identiﬁed as CD45+CD3-CD19-CD14-
HLA-DR- (Supplementary Fig. 3). Their phenotypic differences
were visualised by generating a t-distributed stochastic neigh-
bour embedding (tSNE) landscape using all markers not
previously included in upstream gating (Fig. 1b and Supplemen-
tary Table 1)29. We could determine whether certain regions of
this phenotypic space are enriched with cells from the blood
or the decidua by using a nearest neighbour-based method. In
the tissue probability plot, cells surrounded by decidual cells
are coloured blue and those surrounded by peripheral blood are
coloured red (Fig. 1c). Although the majority of markers are
expressed by both PBMCs and dMCs, cells from the two
tissues segregate into distinct hemispheres suggesting that there
is minimal overlap in phenotype. Some markers are largely
restricted to a single hemisphere and known differences are
conﬁrmed by the tSNE analysis (Supplementary Fig. 4). For
example, CD16 and CD57 are enriched in the peripheral blood
hemisphere which contained few cells staining for tissue-
residency markers, CD49a and CD103, which bind collagen IV
and E-Cadherin respectively (Fig. 1d).
Characterisation of dILC subsets. The initial tSNE analysis
shows considerable heterogeneity within the dILC niche. To
characterise this diversity and identify which dILC subsets are
present, a new tSNE map was generated using Lin- dILCs,
incorporating the surface and intracellular markers indicated in
the ﬁnal column of Supplementary Table 1. Clustering by
DensVM reveals 13 clusters which can be further annotated based
on their proﬁles of marker expression (Fig. 2a, b; Table 1)30.
Some of the clusters present correspond to dNK subsets, dNK1-3,
previously identiﬁed by our scRNA-seq analysis (Supplementary
Fig. 5). This CyTOF analysis permits separation of additional
clusters at high resolution.
The main phenotypic characteristics of the ILC clusters we
have identiﬁed are shown in Table 1. Some of these dNK and ILC
subsets are not easily distinguished by simple marker combina-
tions using traditional 2D gating strategies. The fact that they can
be clearly identiﬁed using mass cytometry combined with tSNE,
illustrates the utility of this approach. The four clusters 10–13
(c10–13) are all characterised by high levels of KIR expression.
Together, they represent the dNK1 subset and the clusters are
distinguished by their combinatorial KIR expression patterns.
Cluster 9 (c9) identiﬁes a distinct dNK subset expressing high
levels of NKG2A but lower levels of KIR, and Eomes compared
with dNK1. Based on similarities to the dNK2 subset identiﬁed by
scRNA-seq we refer to c9 as dNK2 hereafter (Supplementary
Fig. 5). Clusters 5 and 8 (c5, c8), which correspond to dNK3,
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differ in their NKp44 and NKG2A expression and resemble
ieILC1 in other mucosal sites. A proliferative subset with high Ki-
67 levels corresponding to dNKp (c7) is also present. dNK are
known to proliferate in vivo and based on their expression of
moderate levels of KIR and NKG2A and low expression of CD117
and CD127, we believe the Ki-67+dNKp population represent a
mixture of dNK cells, including dNK1, that are dividing within
decidual tissue10. dNK1 (c10–13) are the most abundant subset
identiﬁed in cryopreserved dILCs (30%), followed by dNK2 (c9,
~15%) and dNK3 (c5, c8, ~15%) (Fig. 2c). The proportion of
dNK1 in freshly isolated samples was even greater than for
cryopreserved samples (Supplementary Fig. 2F).
Although ILCs often show tissue-speciﬁc phenotypes, which
can present problems for identiﬁcation, we conﬁrm that a
decidual ILC3 cluster (dILC3) which is CD127+CD117+ is
present (c6) containing both LTi-like and NCR+dILC3s7. We
could not conﬁdently identify dILC2s with our panel due to the
absence of ILC2-speciﬁc markers, but small numbers of CD56
−CD127+CD161+Tbet− cells are present within c3, suggestive
of ILC228. Previous authors have described three main dNK
populations, deﬁned by NKp44 and CD103 expression6. We ﬁnd
these populations spread across our tSNE map suggesting these
markers do not correlate directly with the subsets deﬁned by
CyTOF (Supplementary Fig. 6).
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Fig. 1 Decidual ILC subsets identiﬁed by mass cytometry. aWorkﬂow summary for the analysis of cryopreserved matched blood and decidual samples by
mass cytometry. b t-Distributed Stochastic neighbour embedding (tSNE) landscape of matched CD45+ Lineage negative (Lin−) (CD3, CD19, CD14, HLA-
DR) decidual and peripheral blood mononuclear cells (n= 6). The algorithm incorporated markers indicated in ﬁnal column of Supplementary Table 1 to
generate the tSNE landscape. c Nearest-neighbour-based tissue probability plot indicates the relative distribution of decidual and peripheral blood derived
CD45+ Lin− cells within an area of the tSNE landscape. Blue= surrounded by decidual cells, Red= surrounded by peripheral blood cells, White=
surrounded by mixed cells. d The tSNE landscape is coloured according to relative expression intensity of indicated markers. Red= high expression, Blue=
low expression. Cytofkit and R studio were used to perform these analyses. Source data are provided as a Source Data ﬁle.
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Decidual tissue preparations always contain peripheral blood
cells and these pbNK occur as two clusters (c1, c2), distinguished
by CD16 or CD57 expression. Immuno-histochemistry has only
revealed sparse CD56+CD16+NK cells within the decidua itself3
and these clusters represent contaminants from maternal blood.
Cluster 4 (c4) are CD56+ cells characterised by lower expression
levels of all canonical dNK markers. These dNK have low CD49a
expression, (not seen in stains of matched non-cryopreserved
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Fig. 2 Characterisation of dILC subsets. a Density-based local maxima cluster With SVM (DensVM) clustering of CD45+Lin− (CD3,CD19,CD14,HLA-
DR) cryopreserved decidual cells using mass cytometry data on markers indicated in Supplementary Table 1 (n= 12). b Heatmap displaying mean
expression of indicated markers across the 13 annotated clusters. Values have been scaled by column to show relative expression. c Donut plot showing
the average frequencies of identiﬁed clusters from cryopreserved decidual cell preparations (n= 12). d Representative histograms for transcription factors
across denoted subsets: dNK1-3, ILC3, dNKp, and pbNK. Clusters representing each subset are shown in brackets. Source data are provided as a Source
Data ﬁle.
Table 1 Identity of Lin− clusters in Fig. 2, based on phenotype.
Cluster Annotation Phenotype and comment
1 pbNK CD49alo Eomesint Tbethi (++) CD16+CD57+
2 pbNK CD49alo Eomesint Tbethi (++) CD16+CD57−
3 Mixed CD56+/− Heterogeneous group: CD56+/− CD127+/− CD161+/− CD94lo DNAM1+/−AhR+/−
4 Marker Low Low expression levels for many canonical dNK markers e.g., CD56, GzmB, NKp46, NKp30. Loss of CD69, CD49a,
“unhealthy” cells -increased after cryopreservation
5 dNK3 (ieILC1) CD69hi Eomesint Tbethi CD103+NKG2Dhi CD161hi NKp44hi NKG2Alo
6 dILC3 CD127hi CD117hi AhRhi CD94− CD56+/− NKp44+/−
7 dNKp CD69lo Eomesint Ki-67hi NKG2Ahi KIR+/−
8 dNK3 (ieILC1) CD69hi Eomesint Tbethi CD103+NKG2Dhi CD161hi NKp44lo NKG2Ahi
9 dNK2 CD49aint Eomesint Tbetint CD103− NKG2Ahi KIRlo
10 dNK1 CD49ahi Eomeshi Tbetlo NKG2Ahi LILRB1+KIR3DL1+KIR2DL1+KIR2DL3/L2/S2+
11 dNK1 CD49ahi Eomeshi Tbetlo NKG2Ahi LILRB1+KIR3DL1− KIR2DL1+KIR2DL3/L2/S2−
12 dNK1 CD49ahi Eomeshi Tbetlo NKG2Ahi LILRB1+KIR3DL1−KIR2DL1+KIR2DL3/L2/S2+
13 dNK1 CD49ahi Eomeshi Tbetlo NKG2Ahi LILRB1+KIR3DL1−KIR2DL1−KIR2DL3/L2/S2+
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cells) and are non-functional in response to phorbol-myristate
acetate (PMA) plus ionomycin treatment. We conclude that they
are unhealthy cells whose phenotype is altered by cryopreserva-
tion and thus they have been removed from all subsequent
analyses (Supplementary Fig. 2D, E).
We also analysed the transcription factor proﬁles of the main
dILC clusters. dNK1 (c10–c13) express the highest levels of Eomes,
whilst dNK3 (c5, c8) preferentially express Tbet. In comparison,
dNK2 expresses intermediate levels of both, whilst AhR is highest
in dILC3 (Fig. 2d). We also looked for tissue-resident signatures,
expression of inhibitory receptors for self-HLA (NKG2A, LILRB1,
KIR), activating receptor proﬁles and granule content of identiﬁed
subsets (Supplementary Fig. 5). dNK1 (c10-c13) are characterised
by high levels of CD49a, LILRB1, KIR, and granzyme B. In
contrast, dNK3—similar to ieILC1s—(c5, c8) express high levels of
CD103, CD69, CD161, and NKG2D. dILC3 (c6) also express high
levels of CD69 and CD161, but only low levels of NKG2D and
granzyme B. To summarise, our ﬁndings reveal the considerable
heterogeneity amongst dILC subsets with several clusters deﬁned
by phenotypic cell surface markers, intracellular transcription
factors and granule proteins.
dILC responses to unspeciﬁc stimulation or missing self. We
next measured the functional responses of dILC subsets to two
different stimulants. Firstly, dMCs were treated for 4 h with PMA
and ionomycin before staining with the CyTOF antibody panel
(Supplementary Table 1). This included CD107a as a proxy for
degranulation, and intracellular staining of cytokines and che-
mokines GM-CSF, XCL1, IFNγ, MIP1α (CCL3) and MIP1β
(CCL4). GM-CSF (Granulocyte-macrophage colony-stimulating
factor) stimulates haematopoietic stem cells to produce granulo-
cytes and monocytes, but more relevant to the decidua is its
ability to attract EVT17. The role of IFNγ in human decidua is
unclear, whereas it is an essential cytokine for vascular remo-
delling in murine decidua31. XCL1 (lymphotactin), is believed to
act on speciﬁc antigen-presenting DC subsets in tissues and the
receptor is also expressed on EVT15. MIP1α (Macrophage
inﬂammatory protein-1α) binds CCR1, CCR4, and CCR5 and
MIP1β binds CCR5 and CCR8; in other tissues they have been
shown to recruit various leucocytes, including NK cells, neu-
trophils and monocytes.
We generated a new tSNE map after dNK stimulation and used
this to gate manually on the Lin−CD56+ subsets previously
deﬁned in Fig. 2; Table 1. For simplicity, we have grouped the
clusters into conventional pbNK (c1, c2), dNK1 (c10–c13), dNK2
(c9) and dNK3 (c5, c8) (Table 1). This global analysis shows that
dILC subsets differ signiﬁcantly in their capacity to respond
(Fig. 3a and Supplementary Table 4). Consistently across all
functional readouts, the most responsive subset is dNK3, followed
by dNK2. The contaminating pbNK present express CD107a and
produce larger amounts of IFNγ. The most abundant cells, dNK1,
are functionally muted in comparison with dNK3 or dNK2 and
they preferentially produce chemokines such as MIP1β (Supple-
mentary Fig. 7 and Supplementary Table 4). NCR+dILC3s
produce GM-CSF and XCL1 but little IFNγ6,32. The proliferating
cells, dNKp, show low responses for all readouts. The ability of
each dNK subset to mount a polyfunctional response to
stimulation was assessed by examining three functional readouts:
CD107a staining or IFNγ or at least one of the cytokines MIP1α,
MIP1β, GM-CSF, XCL1 (Fig. 3b). Within responding cells,
dNK3 showed the strongest polyfunctional responses; more than
75% upregulating at least two readouts simultaneously, with
~37% of cells expressing all three. In contrast, 60% of dNK1
expressed a single readout, most of which were CD107a− IFNγ−,
indicating these cells are specialised for secretion of cytokines
other than IFNγ. dNK2 displayed intermediate responses. Thus
all three dNK subsets show distinctive patterns of polyfunctional
responses compared to pbNK cells.
Secondly, we co-cultured dMCs with the HLA-deﬁcient, K562
cell line in a classical missing-self assay. The majority of dNK cells
express NKG2A and are educated to detect missing self. Moreover
we selected donors who were heterozygous for group 1 and group 2
HLA-C alleles (C1/C2) so that both KIR2DL1+ and KIR2DL3
+cells are further educated33,34. As with PMA/ionomycin, dNK3
and dNK2 are the most responsive to missing-self (Supplementary
Fig. 8 and Supplementary Table 5), but in this assay dNK2
responses are higher than dNK3. The relative magnitude of
response of each subset therefore depends on the speciﬁc stimulus.
dNK1 cells are once again low responders, consistent with our
previous ﬁndings that show decreased degranulation of dNK
subsets expressing multiple inhibitory NKR in response to K56235.
To determine if there is a more functional subset within the dNK1
compartment, we focused on CD103 because, although this is a
marker of ieILC1s (and indeed is expressed by dNK3), we also see
expression on ~30% of dNK1. CD103+dNK1 produce signiﬁcantly
higher levels of CD107a, MIP1α, MIP1β, and XCL1 in response to
PMA/ionomycin, and increased levels of MIP1β and XCL1 upon
co-culture with K562 cells when compared to CD103− dNK1
(Fig. 3c, d). To summarise, functional differences exist within the
dILC compartment; in both assays dNK3 and dNK2 subsets show
the highest responses, but which subset predominates is stimulus
dependent. We ﬁnd that particular cytokines/chemokines are
produced by speciﬁc subsets and that CD103 expression by some
dNK1 correlates with increased functional responses, demonstrat-
ing further heterogeneity within this subset.
KIR acquisition on dNK and pbNK. Despite the weak func-
tional responses to PMA/ionomycin and missing self, the major
dILC subset, dNK1, has the potential to respond to invading
EVT as they express NKR, including KIR, with ligands on EVT.
Immunogenetic and in vitro studies also suggest that binding of
KIR on dNK to HLA-C on EVT regulates trophoblast invasion
and pregnancy outcome22,23,35,36. In pbNK, due to the sto-
chastic nature of KIR expression37, individual NK cells can
express multiple KIR and acquisition of KIR, CD57 and the loss
of NKG2A is associated with NK cell differentiation38.
Importantly, acquisition of inhibitory KIR that bind self HLA
class I molecules leads to more responsive pbNK cells through
the process of NK cell education33. To study the effects of KIR
on phenotype and function of dNK, we analysed how additional
NKR, transcription factors and proteins present in NK granules
correlate with KIR acquisition on Lin− CD56+dMCs. We
conﬁrm the ﬁndings on pbNK that CD57 and CD16 expression
increases with acquisition of KIR and ﬁnd DNAM-1 also
increases even when KIRs are not stratiﬁed by education status
(Fig. 4a)39. LILRB1, Ki-67, NKp30, and granzyme B, all increase
markedly on dNK with increasing KIR co-expression; these
markers are either constant or show modest changes on pbNK
(Fig. 4b). NKG2A expression decreases on pbNK with
increasing KIR co-expression38 but the majority of dNK are
NKG2A+ and this slightly increases with KIR acquisition
(Fig. 4c). In contrast, NKG2D, CD161, and Tbet decrease on
dNK as KIR co-expression increases; these markers are main-
tained on KIR+pbNK (Fig. 4d). Therefore, acquisition of KIR
in dNK is associated with very different changes in key phe-
notypic markers compared to pbNK. These include LILRB1,
NKG2A, the transcription factor Tbet and granzyme B.
dNK granule content and organisation. We have previously
shown that KIR+ dNK express higher levels of perforin,
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granulysin and granzymes A and B than KIR− dNK8. We
further explored this connection between granule content and
KIR expression on Lin− CD56+dMCs. We ﬁnd that as dNK
acquire more KIR the ﬂow cytometry side-scatter (a proxy for
granularity) increases with each additional KIR. This holds true
for dNK expressing either single inhibitory or activating KIR
(Fig. 5a–d). In contrast, forward-scatter (a proxy for cell size)
did not increase (Supplementary Fig. 9A, B). Using ﬂow cyto-
metry, we went on to analyse the quantities of perforin, gran-
zyme B and granulysin in dNK, compared to pbNK subsets
(Supplementary Fig. 10A). We conﬁrm previous ﬁndings that
perforin and granzyme B levels in dNK are intermediate
between CD56bright and CD56dim pbNK, whereas dNK have
higher levels of granulysin compared to both pbNK subsets40
(Supplementary Fig. 10B).
To investigate the morphology and location of the granules in
more detail, we used electron and confocal microscopy of dNK
and pbNK. Granules in dNK are signiﬁcantly larger than those
in pbNK (~600 nm diameter for dNK, ~200 nm for pbNK)
(Fig. 5e, f) and fewer in number41. Confocal microscopy shows
that perforin, granzymes and granulysin all localised to fewer,
larger structures, consistent with localisation in enlarged granules
as seen by EM. (Fig. 5g). Few large granules are characteristic of
NK cells from CHS patients that are also poor killers27. CHS NK
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cell granules are less clustered around the MTOC and we
therefore measured this in dNK25,27. Analysis of dNK by confocal
microscopy stained for LAMP-1/CD107a and pericentrin (an
MTOC-associated protein) shows that dNK granules are further
away from the MTOC compared to pbNK (Fig. 5h, i)42. In
summary, dNK have distinctive organisation and distribution of
granules compared with normal pbNK. In contrast to pbNK, the
content of granule proteins such as granzyme B increases as dNK
acquire KIR.
dNK responses triggered by activating KIR. pbNK granules
function as Ca2+ ion stores that contribute to increased sig-
nalling capacity so that cells with larger granules produce more
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cytokines when an activating receptor is triggered24. We next
asked whether Lin− CD56+dMCs become more functional as
granule content increases with acquisition of KIR (Figs. 4b,
5a–d). When analysed by FACS, these Lin− CD56+KIR+
correspond mostly to dNK1 identiﬁed by mass cytometry. We
conﬁrm that, unlike pbNK, degranulation of dNK decreases
with increasing KIR expression in response to missing self, and
cytokine production follows this trend (Fig. 6a)43. In contrast,
Fig. 5 dNK granule content and organisation. a Granule content represented as geometric mean ﬂuorescent intensity (gMFI) of side scatter in Lineage
negative (Lin−) CD56+ cell subsets co-expressing 0–3 Killer-cell Immunoglobulin-like Receptors (KIRs, n= 11). Lines connect dNK subsets from the same
individual. b Fold increase in side scatter over previous data-point in a. c Geometrical mean ﬂuorescence intensity (gMFI) of Granzyme B in KIR2DS1-
KIR2DS4- Lin-CD56+ cells co-expressing 0–2 inhibitory KIRs (n= 11). d Granzyme B gMFI in KIR2DL1-KIR2DL2/S2/3− Lin-CD56+ cells co-expressing
0–2 activating KIRs (n= 4). e Live Lin-CD56+CD94+dNK and pbNK were FACS-sorted and visualised using electron microscopy. Electron dense
lysosomal structures are indicated with “L”. Data is representative of four donors. Scale bar indicates 1 μm. f Granule diameter measured by electron
microscopy, aggregated data for multiple cells (n= 33 for dNK and 53 for pbNK). Red lines indicate mean. g Confocal microscopy pictures of pbNK (top)
and dNK bottom) stained with the markers indicated (green), nucleus (blue) and cell outline (dashed line). Representative 2D views of multiple cells from
ﬁve experiments are shown. White scale bar indicates 2 μm. h 3D representation of four pbNK (top) and two dNK cells (bottom) stained for centrosome
(MTOC, pericentrin, red), CD107a/LAMP-1 (green) and nucleus (blue). Spots (CD107a/LAMP-1) and surfaces (pericentrin, DAPI for nucleus and
Phalloidin for cell surface) created in Imaris are shown. The side of each square in the 3D cube represents 2 μm. i Quantiﬁcation of multiple distance
measurements from CD107a/LAMP-1 structure centre (green spots) to centrosome centre (red surfaces) in h. Line indicates mean. Dots represent
average distances in each cell analysed (n= 18 and 9), from three different experiments with unique unmatched donors. a–c Stars indicate signiﬁcance
obtained with two-tailed one-way ANOVA of matched data points with Tukey correction. Tests were only performed on full series. **p < 0.01, ***p < 0.001,
****p < 0.0001. f, i Stars indicate signiﬁcance obtained with a two-tailed Mann–Whitney test with 95% conﬁdence level, ****p < 0.0001, **p < 0.001. Source
data are provided as a Source Data ﬁle.
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Fig. 6 dNK responses triggered by activating KIR. a Representative XCL1 and CD107a staining by CyTOF in lineage negative (Lin−) CD56+ decidual cells
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following PMA/ionomycin stimulation, there is no obvious
decrease in response with increasing KIR expression (Fig. 6b).
However, these are not physiological stimuli. We have shown
that triggering activating KIR2DS113,17 and KIR2DS415 on dNK
to mimic recognition of HLA-C on trophoblast, results in pro-
duction of cytokines that enhance EVT cell migration in vitro.
Furthermore, these activating KIR are associated with a reduced
risk of developing pre-eclampsia15,22,35,36. When dNK are sti-
mulated by cross-linking KIR2DS4, we now show that increased
KIR co-expression on KIR2DS4+dNK is associated with
increased cytokine production and degranulation (Fig. 6c). A
higher proportion of dNK express both readouts as the number
of KIR expressed goes up, so polyfunctionality of dNK correlates
with KIR co-expression. dNK with highest side scatter also have
the highest cytokine production supporting the link with
increased granule content (Fig. 6d). In summary, dNK with
more KIR display increased functionality when triggered via an
activating KIR in contrast to stimulation via missing self, where
dNK responsiveness decreases with more KIR.
Discussion
We have used CyTOF to proﬁle the phenotype and function of
tissue-resident ILCs in human decidua. Comparison of 13 phe-
notypic subsets of Lin− dILCs by CyTOF with scRNAseq tran-
scriptomic proﬁles deﬁning dNK1–3, dNKp, dILC3, and pbNK
conﬁrms the identity of the major blood and decidual ILC
populations at the protein level with a greater degree of resolu-
tion. Four clusters of dNK1 are deﬁned by KIR co-expression
patterns and two dNK3 sub-populations are distinguished by
NKp44 and NKG2A expression. Based on the similarities between
our RNA proﬁles and CyTOF data we also conﬁrm the presence
of the dNK2 subset. NK transcription factors are under-
represented in scRNAseq due to their low expression levels;
here we ﬁnd that dNK1 are EomeshighTbetlow, in contrast to
dNK3 which are EomesintTbethigh. dNK2 express intermediate
levels of both Eomes and Tbet suggesting that they might be
positioned along a differentiation trajectory between dNK3 and
dNK1. In agreement with previous reports, NCR+ILC3 and LTi-
like dILC3s are present but it is difﬁcult to reliably deﬁne the
sparse dILC2 subset4,5,7.
Heterogeneity of dILC has been described by conventional ﬂow
cytometry for a range of phenotypic markers including KIR, other
NKR and integrins6,44,45. For example, three dNK populations
were deﬁned by ﬂow cytometry on the basis of NKp44 and
CD103 expression but comparison with our high dimensional
analysis using CyTOF (Supplementary Fig. 6) shows the difﬁculty
of capturing the true complexity of dILCs using only a few
markers6. We also did not identify a cluster directly corre-
sponding to “pregnancy trained dNK cells” (PTdNK), although
they do most closely resemble dNK1 that have higher levels of
NKG2C, LILRB1, KIR, and glycolytic enzymes8. Decidual PTdNK
proportionally increase in women after their ﬁrst pregnancy12 but
this clinical information was not available under our ethical
permission for the study.
We obtained this data using frozen cells but there are two
caveats: some markers such as CD49a are more sensitive to the
freeze/thawing process and a cluster of unhealthy cells was
removed from the analysis because it is largely absent from
freshly isolated cells. This is a small study and we were therefore
unable to detect differences resulting from gestational age.
Characterising the spatial dynamics of dILC subsets was also not
within the scope of this study. Finally, as the samples are from
early in gestation, how dILCs are altered in disorders of pla-
centation such as pre-eclampsia which only present later in
pregnancy is undetermined.
The relationship of these human dILC subsets to those in
murine decidua is unclear. There are three murine Group 1 ILC
subsets: CD49a+Eomes- uterine ILC1 (uILC1), CD49a+Eomes
+trNK and CD49a-Eomes+conventional NK (cNK)4,46,47.
Murine uILC1 express CXCR6 and may represent memory cells
as they expand in second pregnancies46. They therefore could be
functionally analogous to KIR+PTdNK, although they have low
levels of Ly49. trNK resemble dNK1 with higher levels of Ly49,
Eomes and Ki-6746,47. Although murine cNK are similar to our
pbNK clusters, these are abundant within murine decidua basalis
whilst CD16+pbNK are only sparse in human decidual tissue4,48.
Human dNK3 resemble ieILC1s for which a murine counterpart
has been characterised in the gut (NKp46+NK1.1+CD160+)49.
However, uterine trNK and uILC1 are both present in Nﬁl3−/−
mice, so neither subset directly corresponds to NFIL3-dependent
gut ieILC1s50. The inability to easily correlate murine and human
uterine ILC subsets could reﬂect the considerable anatomical
differences in placentation between mice and humans. A better
functional characterisation of dILC subsets in both species may
reveal functional homologies among phenotypically
different cells.
dNK are phenotypically and functionally unlike other trNK
present in many human tissues9. CD49a+liver-resident NK cells
(lrNK) express KIR but not NKG2A, whilst CXCR6+lrNK
express NKG2A and not KIR51–53. The main lung NK cells are
circulating CD56dim CD16+, with a smaller CD56bright NK
population expressing CD69, CD49a, and CD10354,55. Unlike
dNK1, these CD56bright lung NK express less KIR2DL2/L3 than
lung CD56dimCD16+NK54. Differentiating CD56dim pbNK
acquire KIR and CD57, lose NKG2A, and increase responsiveness
with acquisition of inhibitory KIR speciﬁc for self-MHC, through
NK education33,38. dNK are quite different because as KIR co-
expression increases, we ﬁnd dNK1 exhibit decreased respon-
siveness to stimulation by missing self, but greater responses to
cross-linking activating KIR2DS4. This paradoxical ﬁnding might
be explained by our ﬁndings that side-scatter and granzyme B
expression also rise with increasing KIR, suggesting changes in
granule content and organisation8,40. We also ﬁnd that the
increased levels of granzyme B reported in dNK expressing
KIR2DS1+40, occurs with both activating and inhibitory KIR.
The different functional responses of dNK and pbNK as they
acquire more KIR, may be due to the differences observed in
granule organisation between the two. Granzyme B accumulates
in granules corresponding to secretory lysosomes and here we
show that dNK granules are larger and located further away from
the MTOC compared to resting pbNK. dNK were previously
shown to be unable to polarise their MTOCs and perforin-
containing granules to the immune synapse56. Enlarged granules
and higher granzyme B expression are linked to increased func-
tional capability in pbNK24. In pbNK, larger granules appear to
act as stores leading to increased Ca2+ release upon receptor
cross-linking and greater degranulation and cytokine release. The
parallel increase in granule proteins and responsiveness to KIR
cross linking as number of KIR increases, suggests a similar
mechanism may operate in dNK. All these features of dNK
granules resemble the pbNK from CHS patients that are poorly
cytotoxic but maintain the capacity to produce cytokines25,26,42.
The genetic mutation responsible for CHS affects the lysosomal
trafﬁcking regulator, LYST. Lyst is mutated in beige mice who
reproduce normally and show similar morphological and func-
tional defects to CHS patients in peripheral but not in uterine NK
cells57,58. Furthermore, normal pregnancy is reported in CHS
patients59. Although a reliable antibody is not available, LYST
mRNA levels are lower in dNK compared to CD56dim pbNK8,60.
Future work is needed to study the biology of these unusual dNK
granules. Indeed, the presence of unique cells in decidua with
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large cytoplasmic granules, led to the original discovery of uterine
NK cells. Their large granules have unique tinctorial properties
(phloxine tartrazine in humans and the lectin DBA in mice) not
seen in NK cells in other tissues61,62.
The major dILC subsets (dNK1-3, dILC3) produce factors
(GM-CSF, XCL1, MIP1α, and MIP1β) whose receptors are
expressed by EVT and thus are likely to modify invasion. This is
stimulus dependent and does not always correlate with the resting
mRNA levels found from scRNAseq8. Indeed, the dominant cells,
dNK1, whose receptor proﬁle suggests direct interactions with
EVT, respond poorly to classical methods used to stimulate NK.
Instead, when trophoblast recognition is simulated by cross-
linking of KIR2DS4, these cells degranulate and make XCL1. KIR
and their HLA-C ligands are highly polymorphic and immuno-
genetic studies show that speciﬁc combinations of maternal KIR
and their HLA-C ligands leading to dNK inhibition are associated
with fetal growth restriction and pre-eclampsia where trophoblast
transformation of uterine arteries is defective. Combinations that
promote dNK activation are associated with enhanced fetal
growth22,23,36. Our results show how KIR may regulate responses
of the dNK1 subset to EVT during pregnancy. Increasing KIR
expression in dNK1 is associated with higher granzyme B levels,
changes in the organisation of granules and with higher
responsiveness of dNK1 to cross-linking activating KIR2DS4 but
lower responses in missing self assays. This suggests responsive-
ness is regulated differently by KIR in dNK compared to pbNK.
The exact roles of the other dILC subsets remains less clear.
dNK2 and dNK3 produce signiﬁcantly higher levels of cyto-
kines such as XCL1, than dNK1 upon missing-self or PMA/
ionomycin stimulation. The only maternal cell expressing
XCR1 in decidua are dendritic cells (cDC1)8 indicating XCL1
derived from dNK2 and dNK3 may recruit and modulate the
functions of cDC1 in decidua as demonstrated in the tumour
microenvironment63. dNK2 and dNK3 express NKR for non-
HLA ligands expressed on EVT—TIGIT binds to PVR and
KLRB1 binding to CLEC2D. They also secrete MIP1α (CCL3)
and MIP1β (CCL4) which can bind to CCR1 and the scaven-
ging receptor, ACKR2 (D6), both expressed by EVT64,65. Loss
of Ackr2 in murine fetal cells leads to placental defects and fetal
death66. To investigate the effects of cytokines and chemokines
derived from dILC subsets in humans requires in vitro
experimental models. We have now developed 3D organoid
culture systems derived from both maternal endometria and
placentas8,67. The trophoblast organoids can be induced to
differentiate into invasive HLA-G+EVT. This characterisation
of the unique features of decidual ILCs, will now permit future
studies of their functional interactions with other decidual cells
as well as fetal trophoblast. The uterine mucosa is dedicated to
supporting the developing placenta and these distinctive ILCs
must be pivotal in ensuring reproductive success.
Methods
Patient samples. Decidual samples were obtained from healthy women with
apparently normal pregnancies undergoing elective ﬁrst trimester terminations
(7–12 weeks) (n= 28). The age and parity of the women is not known to us. All
decidua donors supplied fully informed consent and ethical approval was granted
by the Cambridge Research Ethics Committee (study 04/Q0108/23). Peripheral
blood was taken from women undergoing elective ﬁrst trimester terminations
(7–12 weeks). In addition, whole blood samples were purchased from the NHS
Blood and Transplant unit (n= 4, used in Fig. 4). The age of donors and sex of
NHS Blood and Transplant donors is unknown. All peripheral blood donors
supplied fully informed consent and ethical approval was granted by the Cam-
bridge Research Ethics Committee (study 04/Q0108/23).
Cell lines. The murine cell line P815 and human cell line K562 were purchased
from DSMZ in Germany. Cells were not tested for mycoplasma contamination nor
authenticated and were cultured in complete medium (RPMI1640 medium, anti-
biotics, 10% FCS).
Isolating mononuclear cells from decidua and whole blood. Matched peripheral
blood and decidua samples were collected from women undergoing elective ter-
minations of ﬁrst trimester pregnancies. Peripheral blood mononuclear cells
(PBMCs) were isolated from whole blood by Pancoll (PAN-Biotech) and cryo-
preserved in 90%FCS/10%DMSO. To isolate decidual mononuclear cells (dMCs),
decidual tissue pieces were ﬁrst washed in RPMI-1640 and remaining blood clots
and vessels removed using scalpels. Remaining tissue was then minced and 5 ml of
Collagenase IV (0.1 g/100 ml, sigma) in RPMI-1640 with 10% FCS added for
further dissociation by GentleMACS. The tissue was incubated for another 45 min
at 37 °C whilst being gently shaken. The collagenase was quenched by addition of
RPMI-1640 and then ﬁltered through 100 µm and then 40 µm ﬁlters. dMCs were
isolated following a Pancoll centrifugation step and then cryopreserved in 90%FCS/
10%DMSO. This protocol has been adapted from Male et al. 201268. Additional
whole blood samples were purchased from the NHS Blood and Transplant unit and
PBMCs were isolated and cryopreserved as described above.
Cell staining and data acquisition by mass cytometry. PBMCs and dMCs were
thawed and washed in complete medium. Cells were then rested overnight at 37 °C
with 5% CO2 in complete medium supplemented with 2.5 ng/ml IL-15 (Peprotech).
After resting, cells were washed in serum free RPMI 1640 medium and a viability
stain performed using 500 µM rhodium DNA intercalator diluted 1 in 500 (Flui-
digm Sciences) for 15 min at 37 °C with 5% CO2. Cells were washed in cell staining
medium (CSM, 1× PBS, 0.03% BSA, 2 mM EDTA), counted and distributed at
2–4 × 106 cells per well and stained for 1 h at 4 °C in 65 µl of ﬁltered antibody
mixture. Cells were then washed twice in CSM and ﬁxed in 1% PFA overnight at
4 °C. After ﬁxation, cells were washed in CSM and resuspended in Permeabilization
Buffer (Invitrogen) for 45 min at 4 °C before staining with 65 µl of ﬁltered antibody
mixture for 1 h at 4 °C. Cells were then washed thrice in CSM and DNA stained
using 125 µM Cell-ID Intercalator Ir (Fluidigm Sciences) diluted 1 in 10,000 in 1%
PFA overnight. Finally, cells were washed twice in CSM and then twice in MiliQ
water before acquisition on a Helios mass cytometer.
Cell staining and data acquisition by ﬂow cytometry. PBMCs and dMCs were
thawed and washed in complete medium. Cells were then rested overnight at 37 °C
with 5% CO2 in complete medium supplemented with 2.5 ng/ml IL-15 (Peprotech).
Cells were then counted and distributed at approximately 1 × 106 cells/well in
200 µl FACS wash (FW, 1× PBS, 2% FCS, 2 mM EDTA). Cells were stained for 1 h
at 4 °C and KIR2DS1 was detected by direct addition of 11PB6 antibody to wells for
the last 15 min of staining. Viability was assessed using LIVE/DEAD Aqua incu-
bated for 30 min at 4 °C. Cells were then ﬁxed in 1% paraformaldehyde for 10 min
at room temp and later analysed on a LSR Fortessa (BD Biosciences). For intra-
cellular staining FoxP3 transcription factor staining kit was used for ﬁxation and
subsequent intracellular staining (Invitrogen).
NK were gated on as live CD3-CD14-CD19-CD56+lymphocytes. Further
gating on subsets was done as indicated in ﬁgure legends. The following antibodies
and reagents were used: LIVE/DEAD discriminator (LifeTechnologies), CD3
(UCHT-1, BioLegend), CD14 (M5E2, Biolegend), CD19 (HIB19, BioLegend),
CD56 (HCD56, BioLegend) NKG2A (Z199, Beckman Coulter and REA110,
Miltenyi), KIR2DL1 (REA284, Miltenyi), KIR2DL1/S1 (11PB6, Miltenyi),
KIR2DL3 (180701, RnD Systems), KIR2DL2/3/S2 (CH-L, BD Biosciences and
GL183, Beckman Coulter), KIR2DS4 (REA860, Miltenyi), Perforin (dg9,
BioLegend), Granzyme A (CB9, eBioscience), Granzyme B (GB11, BioLegend),
Granulysin (9/15 kDa, DH2, BioLegend). XCL-1 (109001, RnD systems) was
conjugated to ﬂuorescent molecules using Lightning-Link (Innova Biosciences,
UK). Biotinylated antibodies were detected using Streptavidin Qdot605
(LifeTechnologies).
Antibody conjugation for mass cytometry. Antibodies and isotopes were
obtained from the sources speciﬁed in Supplementary Table 1. Where antibodies
required conjugation, this was performed using MaxPar X8 labelling kits (Fluidigm
Sciences) according to the manufacturer’s instructions.
Stimulation with PMA/ionomycin and missing self. PBMCs and dMCs were
thawed and rested overnight in low dose IL-15 as described above. For stimulation
by PMA/Ionomycin, 1 × 106 mononuclear cells were treated with eBioscience™ cell
stimulation cocktail (Invitrogen) for 4 h in 96-well U bottom plates at 37 °C, 5%
C02. Golgi Plug (BD Biosciences) and Golgi Stop (BD Biosciences) were added for
the ﬁnal 3 h of stimulation. For K562 stimulations, mononuclear cells were co-
cultured with K562 target cells at a ratio of 10:1 for 6 h in 96-well U bottom plates
at 37 °C, 5% CO2. Golgi Plug (BD Biosciences) and Golgi Stop (BD Biosciences)
were added for the ﬁnal 5 h of stimulation. Cells were then stained and acquired as
outlined above. To analyse polyfunctional NK responses to stimulation, Lin−
CD56+ subsets were manually gated on the tSNE plot to show dNK1 (c10–c13),
dNK2 (c9), dNK3 (c5, c8), and pbNK (c1, c2) subsets. Boolean gating arrays were
created using FlowJo to determine the frequency of cells within these subsets that
stained for one, two, or three readouts. Readouts were deﬁned as: CD107a and/or
IFNγ and/or at least one of the cytokines MIP1α, MIP1β, GM-CSF, XCL1 (Cyto).
Non-responding cells that expressed none of the functional readouts were
excluded.
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Stimulation with activating KIR. Cryopreserved decidua cells from previously
KIR-phenotyped KIR2DS4+ donors were used to perform redirected antibody-
stimulation assays. Adherent cells were depleted by plating thawed decidua cells in
T175 ﬂasks over-night. Ten million cells per ﬂask were used in 10 ml of RPMI 1640
with 10% heat-inactivated fetal calf serum and antibiotics, supplemented with
2.5 ng/ml IL-15 (Peprotech). Next day non-adherent cells were washed off using
complete medium and cells were resuspended at 2.5 × 106/ml. P815 cells were
resuspended at 0.5 × 106/ml and coated with anti-KIR2DS4 (clone 179315, R&D
Sytems) or isotype control by adding 5 µg/ml antibody and incubating 30 min at
four degrees.
Effector and target cells were then mixed at 5:1 ratio (100 μl of each) in a
U-bottom plate. Plates were centrifuged for 2 min 300 rpm followed by incubation
1 h at 37 degrees. GolgiPlug and GolgiStop (BD Biosciences) were then added
according to manufacturer’s instructions. After an additional 5 h of co-incubation
at 37 °C, 5% C02, cells were transferred to V-bottom plates for FACS staining.
Confocal microscopy. FACS-sorted (same gating as above with addition of
CD94/NKG2A positivity) or MACS-puriﬁed NK cells were used (purity veriﬁed
>95% by same FACS panel as here above). NK cell negative selection kit was
used for MACS-puriﬁcation (Miltenyi). 10–50,000 NK cells were stained in V-
bottom 96 well plates. DAPI was used for DNA stain of nucleus. The following
primary antibodies were used perforin (dg9, BioLegend), Granzyme A (CB9,
eBioscience), Granzyme B (GB11, BioLegend), Graunulysin (9/15 kDa, DH2,
BioLegend, Pericentrin (Rabbit polyclonal, ab4448, Abcam), LAMP-1 (H4A3,
BioLegend). Primary antibodies were detected using goat-anti-rabbit (for peri-
centrin) or goat anti-mouse isotype-speciﬁc antibodies conjugated to Alexa
Fluor 488, 647, or 568.
Antibodies were incubated for 1 h at room temperature. Fixation was done
with 2% PFA in PBS buffer. Permeabilisation was done with a 1% BSA, 0.4%
saponin PBS buffer. Following staining and washing in V bottom plate, cells
were transferred to 15-well µ-Slide Angiogenesis (ibidi) pre-coated with Cell-Tak
(Corning). Slides were centrifuged for 2 min 300 rpm to let cells settle. Cells were
then covered with ProLong Gold Antifade (ThermoFisher). Samples were
imaged at room temperature with an Andor Revolution Spinning disk system
with CSU-X1 spinning disk (Yokogawa), 512 × 512, 16 μm2 pixel camera (iXon,
Andor) IX81 microscope (Olympus) using the 60× or 100× objective (numerical
aperture 1.45) and 2.5× camera adaptor and with lasers exciting at 405, 488, 561,
and 640 nm. Images were acquired using IQ2 (Andor) and processed using
IMARIS software (Bitplane). The spots and surface functions were used to deﬁne
structures between which distances were then measured using Imaris.
Electron microscopy. FACS-sorted NK cells (same gating as above with addition
of CD94 positivity) were immediately ﬁxed in 0.5% glutaraldehyde in 0.2M sodium
cacodylate buffer (pH 7.2) for 30 min. They were then washed in sodium caco-
dylate buffer, treated with reduced osmium tetroxide 1% OsO4, 1.5% potassium
ferricyanide at room temperature for 60 min, washed in water, treated with 0.5%
magnesium uranyl acetate at 4 °C for 16 h, dehydrated with ethanol rinsed in
propylene oxide and embedded in Epon resin. Ultrathin sections were examined in
a FEI Tecnai G2 TEM at 80 kV. Images were acquired with a MegaView III CCD
and Soft Imaging Systems programme.
KIR and HLA genotyping. Genomic DNA was isolated from whole blood samples
using the QIAamp DNA Mini Blood Kit (Qiagen). For decidua samples, the tissue
was ﬁrst digested using proteinase K and RNase A (Roche) in combination with
tissue lysis and protein precipitation buffers (Qiagen). DNA was subsequently
precipitated using isopropanol. Genotyping for KIR gene presence and HLA-C1/C2
status was performed by PCR-SSP using validated methods22,23.
Statistical analysis. FCS ﬁles were analysed with FlowJo v10.5.3 (Tree Star Inc.).
tSNE, DensVM clustering and nearest neighbour-based tissue probability analyses
were performed using the R packages cytofkit and DepecheR from
Bioconductor69,70. Statistical analyses were largely performed using PRISM
(GraphPad Software Inc.) and the open source statistical package R (www.r-
project.org). Datasets were tested for normal distribution and the appropriate
statistical test was then used to compare subsets. Methods used are speciﬁed in
ﬁgure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available
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